% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • racavalli racavalli Jan 29, 2013 3:13 PM Flag

    the article blasting AMPE is working well to help the shorts cover their position before major news hits

    Today's article is so obvious that it is an attempt to shake the tree hard so the shorts can gather al the stock they need to cover their short positions before a major announcement is released.

    If AMPE were vetted by major bankers and had a decent following, it would be at least a $20 stock today based on actual comps of what is out there now.

    Too bad though, it is not and we all have to sit tight and wait until the company makes an announcement. In the meanwhile, this article and the rest to surely follow will most likely drive the stock much much lower because it is way too easy to manipulate with articles by the shorts who are the only ones who are writing about the company that remains silent.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "If AMPE were vetted by major bankers and had a decent following"

      Why hasn't AMPE been vetted by major banks?

      "it is way too easy to manipulate with articles by the shorts who are the only ones who are writing about the company that remains silent."

      Interesting. I wonder if longs ever write articles to manipulate AMPE......

      • 2 Replies to ampiooooooh
      • This is a key question to the current valuation problem the company has had since day 1.

        When Ampio's shareholders and management decided to become a publicly traded company, they weighed their options. 1 - do traditional IPO and take a year longer and pay a million or more in the a shelf company that is already approved for trading and is deemed to be liability free.

        To save time and money, they chose to buy a shelf company. That meant that no known bankers EVER had any knowledge of the company. No bankers ..... Except for the questionable and not followed Aegis and Fordham . . . . No coverage . . . . no visibility except for the visibility I brought to the company with my articles that were all true and where everything was substantiated.

        The basic simple fact that absolutely cannot be denied is that INVESTORS WILL NOT INVEST TO ANY SIGNIFICANT DEGREE IN ANY STOCK THAT IS NOT FOLLOWED BY MAJOR BANKERS. THAT IS A SIMPLE FACT. Look as hard as you can and you will never find any company whose stock did well for any extended period of time that was not covered by major or well known analysts and bankers.

        The only bankers the company has ever dealt with are tow very tiny, very unknown and very unfollowed firms called Fordham and Aegis.

        If you look into this, you will see that there is not one known banker who covers AMPE.

        Management says they don't want to pay the high fees.

        I undertand, but the big question is ...... was this wise?

        I personally do not think so because if they did the traditional IPO path, based on current comps in the marketplace, AMPE shares would be selling between $20 per share instead of $3.00 and headed lower for the short term.

        I have been accused of writing articles to pump the stock which implies there is going to be a dump and somebody will profit. First, there has never been a seller trying to take advantage of my articles and second, my ONLY mission was to share their unusually exciting story with the investment community that knows nothing about them and still doesn't because management doesn't have a clue about how their shares are valued and they certainly does not know how to get their story out. Everytime they issue a press release that is good news, the stock drops. What does that tell you.

        I believe this company knows what it is doing with their business and is going to surprise on the upside eventually even in spite of themselves, but I also believe their shares would be much much higher today , , , , and tomorrow, if they only knew how to get out of their own way and talk to shareholders the same way the more successful companies do.

        Sentiment: Strong Buy

      • let us not forget that the biggest moron Adam F likes to bash and help the shorts every now and then. It's a shame that he is a journalist and covers biotech/pharma.

0.75+0.01(+1.42%)Oct 24 4:02 PMEDT